Efficacy of High-Dose Intravenous Methylprednisolone in Ethambutol-Induced Optic Neuropathy: Insights from a Double-Blind RCT

Highlight

This first randomized controlled trial (RCT) assessing corticosteroid therapy in ethambutol-induced optic neuropathy (EtON) demonstrates that high-dose intravenous methylprednisolone (IVMP) significantly improves the proportion of patients with visual acuity gain and enhances visual field parameters compared to placebo. Importantly, no serious adverse events were reported with IVMP administration. These findings suggest a potentially effective intervention for a condition traditionally managed only by drug discontinuation.

Study Background and Disease Burden

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply